Aarvik Therapeutics Announces a Global Novel Payload Agreement with NJ Bio, Inc.
HAYWARD, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)-- #ADC--Aarvik Therapeutics announces a global license and assignment agreement with NJ Bio, Inc. for novel payloads with a wide range of potencies.
